Er Yue

816 total citations
14 papers, 671 citations indexed

About

Er Yue is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Er Yue has authored 14 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Er Yue's work include Inflammasome and immune disorders (5 papers), Circular RNAs in diseases (3 papers) and interferon and immune responses (2 papers). Er Yue is often cited by papers focused on Inflammasome and immune disorders (5 papers), Circular RNAs in diseases (3 papers) and interferon and immune responses (2 papers). Er Yue collaborates with scholars based in China, United States and Russia. Er Yue's co-authors include Yunlong Bai, Ying� Qin, Yanan Jiang, Xi Sun, Hui Che, Yueqiu Wang, Jie Lv, Fan Yang, Yahan Yu and Anqi Li and has published in prestigious journals such as Cancer Research, Biochemical Pharmacology and Cell Death and Disease.

In The Last Decade

Er Yue

14 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Er Yue China	11	532	237	133	102	85	14	671
Zahra Hoseini Iran	3	340 0.6×	78 0.3×	37 0.3×	47 0.5×	164 1.9×	4	494
Yinghong Zhu China	14	361 0.7×	115 0.5×	79 0.6×	24 0.2×	60 0.7×	34	682
Mian Wang China	14	487 0.9×	290 1.2×	30 0.2×	24 0.2×	158 1.9×	31	764
Ranchen Xu China	6	351 0.7×	179 0.8×	34 0.3×	42 0.4×	85 1.0×	7	463
Zijing Xia China	16	424 0.8×	242 1.0×	15 0.1×	80 0.8×	56 0.7×	30	754
Zhen Ni China	13	288 0.5×	101 0.4×	38 0.3×	43 0.4×	48 0.6×	27	624
Jufang Chi China	15	288 0.5×	79 0.3×	164 1.2×	18 0.2×	47 0.6×	26	579
Dong Huang China	13	298 0.6×	111 0.5×	166 1.2×	17 0.2×	249 2.9×	31	698
Hongtao Diao China	11	288 0.5×	65 0.3×	89 0.7×	20 0.2×	113 1.3×	20	402

Countries citing papers authored by Er Yue

Since Specialization

Citations

This map shows the geographic impact of Er Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Er Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Er Yue more than expected).

Fields of papers citing papers by Er Yue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Er Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Er Yue. The network helps show where Er Yue may publish in the future.

Co-authorship network of co-authors of Er Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Er Yue. A scholar is included among the top collaborators of Er Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Er Yue. Er Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Garg, Pankaj Kumar, Atish Mohanty, Tamara Mirzapoiazova, et al.. (2023). Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochemical Pharmacology. 217. 115847–115847. 3 indexed citations

Yue, Er, Yahan Yu, Xinyao Wang, et al.. (2021). Anthocyanin Protects Cardiac Function and Cardiac Fibroblasts From High-Glucose Induced Inflammation and Myocardial Fibrosis by Inhibiting IL-17. Frontiers in Pharmacology. 11. 593633–593633. 29 indexed citations

Yue, Er, Guangchao Yang, Yuanfei Yao, et al.. (2021). Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment. Cancers. 13(17). 4265–4265. 11 indexed citations

Yue, Er, Guangchao Yang, Yuanfei Yao, et al.. (2021). Abstract 1153: Targeting CA125 transcription for ovarian cancer treatment. Cancer Research. 81(13_Supplement). 1153–1153. 1 indexed citations

Liang, Rui, Yuanfei Yao, Guangyu Wang, et al.. (2020). Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL. Frontiers in Oncology. 10. 1118–1118. 3 indexed citations

Yang, Fan, Anqi Li, Ying� Qin, et al.. (2019). A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA. Molecular Therapy — Nucleic Acids. 17. 636–643. 104 indexed citations

Tuguzbaeva, Gulnara, Er Yue, Xi Chen, et al.. (2019). PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting v integrin/FAK/Src signaling in oral squamous cell carcinoma cells. Acta Pharmaceutica Sinica B. 9(6). 1163–1173. 28 indexed citations

Syeda, Madiha Zahra, Er Yue, Yanan Jiang, et al.. (2019). Anthocyanidin attenuates myocardial ischemia induced injury via inhibition of ROS‐JNK‐Bcl‐2 pathway: New mechanism of anthocyanidin action. Phytotherapy Research. 33(12). 3129–3139. 15 indexed citations

Li, Anqi, Yahan Yu, Xueying Ding, et al.. (2019). MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway. International Journal of Cardiology. 307. 137–145. 44 indexed citations

10.

Jiang, Yanan, Weijie Du, Qun Chu, et al.. (2018). Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome. Cellular Physiology and Biochemistry. 45(1). 192–202. 42 indexed citations

11.

Yue, Er, Gulnara Tuguzbaeva, Xi Chen, et al.. (2018). Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine. 56. 286–294. 101 indexed citations

12.

Yang, Fan, Ying� Qin, Jie Lv, et al.. (2018). Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death and Disease. 9(10). 1000–1000. 225 indexed citations

13.

Chu, Qun, Anqi Li, Xi Chen, et al.. (2018). Overexpression of miR-135b attenuates pathological cardiac hypertrophy by targeting CACNA1C. International Journal of Cardiology. 269. 235–241. 31 indexed citations

14.

Bai, Yunlong, Xi Sun, Qun Chu, et al.. (2018). Caspase-1 regulates Ang II-induced cardiomyocyte hypertrophy via up-regulation of IL-1β. Bioscience Reports. 38(2). 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact